The Value of Everything
Who Makes and Who Takes from the Real Economy
Artikel konnten nicht hinzugefügt werden
Der Titel konnte nicht zum Warenkorb hinzugefügt werden.
Der Titel konnte nicht zum Merkzettel hinzugefügt werden.
„Von Wunschzettel entfernen“ fehlgeschlagen.
„Podcast folgen“ fehlgeschlagen
„Podcast nicht mehr folgen“ fehlgeschlagen
Nur 0,99 € pro Monat für die ersten 3 Monate
Audible 60 Tage kostenlos testen
The Value of Everything
Für 24,95 € kaufen
-
Gesprochen von:
-
Randye Kaye
-
Von:
-
Mariana Mazzucato
Über diesen Titel
The Value of Everything argues that American companies have for too long been valued according to the amount of wealth they capture for themselves rather than for the value they create for the economy. In fact, Pfizer, Amazon, and other companies are actually dependent on public money, spend their resources on boosting share prices and executive pay, and reap ever-expanding rewards without offering the market value.
In her previous work, The Entrepreneurial State, Mariana Mazzucato argued that public investment has been the most significant driver of innovation and product development. The iPhone as it exists would not have been possible without government-sponsored technology like Siri and Touch ID. Yet Apple today, like numerous other companies, is engaging in a massive repurchase scheme, and for the first time has prioritized value-extraction practices such as spending to boost shareholder profit-the very initiatives that funded their software. If private companies continue down this path, they will succeed in diminishing the size of their largest and most successful investor - the state - and will destroy powerful opportunities, shrivel markets, and depress wealth.
©2018 Mariana Mazzucato (P)2018 HighBridge, a division of Recorded Books
A couple of very good thoughts, questions, and insights= 5 stars; unfortunately also a couple pf poor sections that appeared dogmatic, e.g. on share buybacks; I prefer Warren Buffett’s perspective on the topic. Other sections that were biased include drug pricing and venture capital.
Pharmaceutical development and venture capitalism usually involve a lot of risk, hence, require a substantial reward in case of success. If failure is privatized, success cannot be socialized. The opposite holds true, as well.
Overall, a qualified recommendation for people with this particular interest; I learned a few things on national accounting.
A few good thoughts, not a must read for most people
Ein Fehler ist aufgetreten. Bitte versuche es in ein paar Minuten noch einmal.